Publications by Melissa Reeves (formerly mccreery)
Fitch B, Zhou M, Situ J, Surianarayanan S, Reeves MQ, et al. Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia. Blood Advances (2021).
Wang H, Song X, Liao H, Wang P, Zhang Y, Che L, Zhang J, Zhou Y, Cigliano A, Ament C, Superville D, Ribback S, Reeves M, et al. Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans. Hepatology, 74, 248-263 (2021).
Dodagatta-Marri E, Meyer DS, Reeves MQ, et al. α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas. J. Immunother. Cancer 7, 1-15 (2019).
Reeves MQ*, Kandyba E, Harris S, et al. Multicolour lineage tracing reveals clonal dynamics of squamous carcinoma evolution from initiation to metastasis. Nat. Cell Bio. 20, 699-709 (2018). (PMID: 29802408)
*Co-corresponding author
Huang PY, Kandyba E, Jabouille A, Sjolund J, Kumar A, Halliwill K, Reeves MQ, et al. Lgr6 is a stem cell marker in mouse skin squamous cell carcinoma. Nat. Gen. 49, 1624-31 (2017). (PMID: 28945253 / PMCID: PMC5662105)
McCreery MQ* and Balmain A. Chemical carcinogenesis models of cancer: Back to the future. Ann. Rev. Cancer Bio. 1, 295-312 (2017).
*Co-corresponding author
McCreery MQ, Halliwill KD, Chin D, et al. Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers. Nat. Med. 21, 1514–20 (2015). (PMID: 26523969 / PMCID: PMC5094808)
Smith CC, Lasater EA, Lin KC, Wang Q, McCreery MQ et al. Crenolanib is a selective type I pan-FLT3 inhibitor. Proc Natl Acad Sci U S A 111, 5319–24 (2014). (PMID: 24623852 / PMCID: PMC3986131)
Rudolph M, McCreery MQ, et al. High chemoselectivity in phenol synthesis. Beilstein J. Org. Chem. 7, 794-801 (2011). (PMID: 21804874 / PMCID: PMC3135103)